Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
Description
Cancer patients are at an increased risk of morbidity and mortality from SARS-CoV-2 infection and have a decreased immune response to vaccination. We conducted a study measuring both the neutralizing and total antibodies in cancer patients following
